| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |